ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 956,65
0,37%
DAX
17 932,17
-1,10%
Brent Oil
83,625
-2,64%
Bitcoin
57 157,16
-5,68%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. NanoVibronix Inc (NAOV)

  7. NanoVibronix Inc (NAOV) Actualités

NAOV NanoVibronix Inc

0,69
-0,045 (-6,12%)
Dernière mise à jour : 19:13:50
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
NanoVibronix Inc NAOV NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,045 -6,12% 0,69 19:13:50
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,723 0,6775 0,7538 0,735
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202414:00BWNanoVibronix Announces PainShield Will Be Included in..
09/4/202414:30BWNanoVibronix Issues Letter to Stockholders
28/3/202413:30BWNanoVibronix Signs Agreement for Research and Development of..
26/2/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202421:45EDGAR2Form SC 13G - Statement of acquisition of beneficial..
17/1/202422:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
17/1/202422:30EDGAR2Form 8-K - Current report
11/12/202322:30EDGAR2Form 8-K - Current report
06/12/202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202315:00BWNanoVibronix Featured in Your Bladder Health Magazine
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202302:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202322:45EDGAR2Form 8-K - Current report
04/12/202315:00BWNanoVibronix Enters into Letter of Intent with APOGEPHA..
28/11/202315:00EDGAR2Form 8-K - Current report
28/11/202315:00BWNanoVibronix Announces Agreement for Clinical Study of..
21/11/202314:30EDGAR2Form 8-K - Current report
21/11/202314:30BWNanoVibronix Regains Nasdaq Compliance
14/11/202314:30BWNanoVibronix Issues Letter to Shareholders
13/11/202322:44EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202314:30EDGAR2Form 8-K - Current report
07/11/202314:30BWNanoVibronix UroShield Products Available on NHS Drug Tariff..
27/9/202314:00EDGAR2Form 8-K - Current report
27/9/202314:00BWNanoVibronix Gains Approval for Inclusion of UroShield..
22/9/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202316:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
21/9/202316:25EDGAR2Form RW - Registration Withdrawal Request
12/9/202322:15EDGAR2Form S-3 - Registration statement under Securities Act of..
06/9/202314:30EDGAR2Form 8-K - Current report
06/9/202314:30BWNanoVibronix Announces Presentation of Positive Independent..
01/9/202322:30EDGAR2Form 8-K - Current report
30/8/202320:29BWNanoVibronix Announces $5 Million Private Placement Priced..
30/8/202314:30EDGAR2Form 8-K - Current report
30/8/202314:30BWNanoVibronix Cites Positive Results from Independent Testing..
29/8/202322:05EDGAR2Form 8-K - Current report
29/8/202322:05BWNanoVibronix Responds to CMS’ Determination for PainShield
28/8/202314:30EDGAR2Form 8-K - Current report
28/8/202314:30BWNanoVibronix Applies for Inclusion of UroShield Products in..
23/8/202322:45EDGAR2Form 8-K - Current report
23/8/202314:45BWNanoVibronix Extends Distribution Agreement with Its Largest..
11/8/202323:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202323:14EDGAR2Form S-1/A - General form for registration of securities..
01/8/202322:30EDGAR2Form S-3 - Registration statement under Securities Act of..
20/7/202322:45EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
NAOV
NanoVibronix
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés